Jimmy Thomas Efird

Dr. Jimmy Thomas Efird

CSPEC/HSR&D/DVAHCS
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Jimmy Thomas EfirdJimmy Thomas Efird
Jimmy Thomas Efird
When planning a randomized clinical trial, careful consideration must be given to how participants are selected for various arms of a study. Selection and accidental bias may occur when participants are not assigned to study groups with equal probability. A simple random allocation scheme is a process by which each participant has equal likelihood of being assigned to treatment versus referent groups. However, by chance an unequal number of individuals may be assigned to each arm of the study and thus decrease the power to detect statistically significant differences between groups. Block randomization is a commonly used technique in clinical trial design to reduce bias and achieve balance in the allocation of participants to treatment arms, especially when the sample size is small. This method increases the probability that each arm will contain an equal number of individuals by sequencing participant assignments by block. Yet still, the allocation process may be predictable, for example, when the investigator is not blind and the block size is fixed. This paper provides an overview of blocked randomization and illustrates how to avoid selection bias by using random block sizes.

AMAbul Hasnat Milton
Abul Hasnat Milton
MRMD Mijanur Rahman
MD Mijanur Rahman
SHSumaira Hussain
Sumaira Hussain
CJCharulata Jindal
Charulata Jindal
SCSushmita Choudhury
Sushmita Choudhury
Jimmy Thomas EfirdJimmy Thomas Efird
Jimmy Thomas Efird
The Rohingya people are one of the most ill-treated and persecuted refugee groups in the world, having lived in a realm of statelessness for over six generations, and who are still doing so. In recent years, more than 500,000 Rohingyas fled from Myanmar (Burma) to neighboring countries. This article addresses the Rohingya refugee crisis in Bangladesh, with special emphasis on the living conditions of this vulnerable population. We reviewed several documents on Rohingya refugees, visited a registered refugee camp (Teknaf), collected case reports, and conducted a series of meetings with stakeholders in the Cox’s Bazar district of Bangladesh. A total of 33,131 registered Rohingya refugees are living in two registered camps in Cox’s Bazar, and up to 80,000 additional refugees are housed in nearby makeshift camps. Overall, the living conditions of Rohingya refugees inside the overcrowded camps remain dismal. Mental health is poor, proper hygiene conditions are lacking, malnutrition is endemic, and physical/sexual abuse is high. A concerted diplomatic effort involving Bangladesh and Myanmar, and international mediators such as the Organization of Islamic Countries and the United Nations, is urgently required to effectively address this complex situation.

1 January 1996 in Neurology
Verified
Journal Article
Open access
PDF file
SCSteven C Cramer
Steven C Cramer
JGJohn A. Glaspy
John A. Glaspy
Jimmy Thomas EfirdJimmy Thomas Efird
Jimmy Thomas Efird
DLDavid N. Louis
David N. Louis
Article abstract-Chronic lymphocytic leukemia is the most common human leukemia but infrequently causes neurologic symptoms. We have reviewed all previously reported cases of chronic lymphocytic leukemia in the CNS along with three new cases; one patient was diagnosed antemortem and treated with immediate improvement and 4-year survival. In addition, we reviewed all autopsy cases since 1972 and available lumbar puncture data on patients with chronic lymphocytic leukemia admitted to the Massachusetts General Hospital. Invasion of the CNS by chronic lymphocytic leukemia often leads to confusional state, meningitis with cranial nerve abnormalities, optic neuropathy, or cerebellar dysfunction. Lumbar puncture shows a lymphocytosis consisting of monoclonal B cells, but CSF cytology studies are of limited value in establishing the diagnosis. Long-term survival may be related to the stage of chronic lymphocytic leukemia at the time of CNS disease and may be associated with intrathecal chemotherapy. A mild, asymptomatic infiltration of the brain, frequently noted in late-stage chronic lymphocytic leukemia in autopsy series, may explain the CSF lymphocytosis in some patients with late-stage chronic lymphocytic leukemia. NEUROLOGY 1996;46: 19-25

20 November 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
TBTithi Biswas
Tithi Biswas
Jimmy Thomas EfirdJimmy Thomas Efird
Jimmy Thomas Efird
SPShreya Prasad
Shreya Prasad
CJCharulata Jindal
Charulata Jindal
PWPaul R. Walker
Paul R. Walker
The survival benefit of neoadjuvant chemotherapy and pCR among patients with advanced stage triple negative breast cancer The survival benefit of neoadjuvant chemotherapy and pCR among patients with advanced stage triple negative breast cancer

Jimmy Thomas EfirdJimmy Thomas Efird
Jimmy Thomas Efird
YCYuk Ming Choi
Yuk Ming Choi
SDStephen W. Davies
Stephen W. Davies
SMSanjay Mehra
Sanjay Mehra
EAEthan J Anderson
Ethan J Anderson
LKLalage A. Katunga
Lalage A. Katunga
Bitter Melon (Momordica charantia) is a widely used traditional remedy for hyperglycemia. While the medicinal properties of this plant have been studied extensively using in vitro and animal models, the clinical efficacy and safety in humans is largely unknown. This review discusses the benefits and limitations of bitter melon supplementation in the context of epidemic levels of insulin resistance and pre-diabetes throughout the world.

28 July 2011 in Nutrition Journal
Verified
Journal Article
Open access
PDF file
LSLaura S Snee
Laura S Snee
VNVivek Nerurkar
Vivek Nerurkar
DDDian A Dooley
Dian A Dooley
Jimmy Thomas EfirdJimmy Thomas Efird
Jimmy Thomas Efird
ASAnne C Shovic
Anne C Shovic
PNPratibha Nerurkar
Pratibha Nerurkar
Background: Although beneficial to health, dietary phytonutrients are bitter, acid and/or astringent in taste and therefore reduce consumer choice and acceptance during food selection. Momordica charantia, commonly known as bitter melon has been traditionally used in Ayurvedic and Chinese medicine to treat diabetes and its complications. The aim of this study was to develop bitter melon-containing recipes and test their palatability and acceptability in healthy individuals for future clinical studies. Methods: A cross-sectional sensory evaluation of bitter melon-containing ethnic recipes was conducted among 50 healthy individuals. The primary endpoints assessed in this analysis were current consumption information and future intentions to consume bitter melon, before and after provision of attribute- and health-specific information. A convenience sample of 50, self-reported non-diabetic adults were recruited from the University of Hawaii. Sensory evaluations were compared using two-way ANOVA, while differences in stage of change (SOC) before and after receiving health information were analyzed by Chi-square (χ2) analyses. Results: Our studies indicate that tomato-based recipes were acceptable to most of the participants and readily acceptable, as compared with recipes containing spices such as curry powder. Health information did not have a significant effect on willingness to consume bitter melon, but positively affected the classification of SOC. Conclusions: This study suggests that incorporating bitter foods in commonly consumed food dishes can mask bitter taste of bitter melon. Furthermore, providing positive health information can elicit a change in the intent to consume bitter melon-containing dishes despite mixed palatability results.